Equity Brief · Healthcare2026-05-20
MDT·Healthcare

Medtronic PLC

I · AI-analyse

In het kort

Medtronic manufactures and sells medical devices across four main areas: heart devices like pacemakers and heart valves, neuroscience products including spinal implants and brain stimulation systems, surgical tools including robotic-assisted surgery platforms, and diabetes management products like insulin pumps and glucose monitors [Company Overview]. The company serves hospitals, physicians, and patients in over 150 countries worldwide.

Medtronic is a major medical device company that makes cardiac devices, spinal implants, surgical tools, and diabetes management systems. The company faces moderate financial health concerns with slowing growth and operational inefficiencies [Yahoo Finance], but it maintains a 48-year dividend growth streak and is investing in AI-powered surgical robotics [Yahoo Finance]. Recent news highlights leadership changes in key divisions and positive momentum in new therapy development [Simply Wall St, Yahoo Finance].

Medtronic shows moderate financial concerns with slow growth and modest returns despite strong cash flow generation.

In het kort AI analysisBetrouwbaarheid 7/10

Sentinellis-score

5.3/10

Moderate concerns

Marktkapitalisatie

$100.9B

Omzet (12 maanden)

$33.5B

II · Recent nieuws

Wat de koers bewoog

6 stories · ranked by relevance

  • macro2026-05-18

    Mental Health Matters at Medtronic. Explore Our Employee Benefits

    Yahoo Finance

  • macro2026-05-19

    Medtronic Neuroscience Appointment Puts Focus On Execution And Growth Risks

    Simply Wall St

  • macro2026-05-18

    Medtronic (MDT) Advances While Market Declines: Some Information for Investors

    Yahoo Finance

  • macro2026-05-18

    Middle East and Africa Wearable Injectors Market Trends and Forecast Report 2026-2035 Featuring Amgen, BD, Biocon, Gerresheimer, Insulet, J&J, Medtronic, Roche, West Pharmaceutical, Ypsomed

    Yahoo Finance

  • macro2026-05-17

    A Once-in-a-Decade Opportunity: 1 Stock to Buy Hand Over Fist and Hold for Years

    Yahoo Finance

  • macro2026-05-14

    Should Medtronic’s AVIM Hypertension Trial Shift Require Action From Medtronic (MDT) Investors?

    Yahoo Finance

Premium · gratis met elk account

Revenue growth of only 3.6% year-over-year is significantly slower than historical medtech sector averages, suggesting Medtronic may be losing competitive ground [Yahoo Finance]

1 van 5 risico's in dit rapport

Risico's

5

Kansen

6

Waarschuwingssignalen

3

Leiding

10

Nog 23 bevindingen in het volledige rapport — gratis met elk account.

Ontgrendel de volledige analyse van Medtronic PLC

Maak een gratis account voor het volledige AI-rapport met bronvermelding in de tekst.

  • 5 risico's, 6 kansen en 3 waarschuwingssignalen — elk met zijn bron
  • Meer dan 100 financiële cijfers met grafieken en vergelijkingen
  • Volledige nieuwssamenvattingen met bronlinks
  • Directie en beloning
  • PDF-export voor offline
Ontgrendel alle 14 bevindingen3 gratis rapporten · geen creditcard

III · Vergelijkbare bedrijven

Misschien ook interessant

Same sector · Healthcare or comparable health

Op je volglijst zetten?

Read three companies free. Geen kaart.

Krijg 3 gratis rapporten